From June 18 to 19, 2026, the 12th China Veterinary Medicine Expo was grandly held at the Hefei Binhu International Convention and Exhibition Center. This exhibition brought together elite professionals from the entire animal health industry across the country, facilitating in-depth discussions on core topics such as green veterinary medicine development, antibiotic reduction and replacement technologies, and the transformation of research and academic achievements. It is considered the top-tier exchange and exhibition platform in the domestic veterinary medicine industry.

Taiyuan Enho Animal Pharmaceutical Co., Ltd. (hereinafter referred to as "Enho") showcased multiple independently innovated products and precise animal disease prevention and control solutions, fully demonstrating the company’s technological innovation accumulation and brand strength built over more than a decade in the animal health sector.

At the exhibition: Full of guests and unprecedented enthusiasm. During the exhibition, Enho’s booth was continuously popular. Many peer companies and livestock clients from various regions stopped by to inquire, engaging in detailed exchanges centered on the company’s core products and green farming solutions. Chairman Xin Lihai explained the core advantages and technical principles of the products on-site, and held in-depth discussions with visiting clients regarding cooperation models and supply channels, creating a lively two-way exchange atmosphere.

It is particularly worth mentioning that Enho’s innovative achievements in the field of new Chinese medicine formulations attracted widespread attention and demonstrated solid technical expertise in Chinese medicine extraction and oral liquid formulations.

Industry Layout: Ten-Thousand-Square-Meter Base, Diverse Coverage

    Founded in 2008 and located in the Small and Micro Enterprise Park in Taiyuan, Shanxi, Enho Pharmaceutical is a high-tech enterprise integrating animal health product research, production, and sales.

It currently has a ten-thousand-square-meter production workshop, covering seven veterinary medicine production lines including powders (D grade)/premixes, granules, oral solutions (including Chinese medicine extracts), disinfectants (liquid, D grade)/external insecticides (liquid, D grade)/ear drops, etc. Meanwhile, Enho’s sister company, Shanxi Langxin Biotechnology Co., Ltd., operates four production lines for mixed feed additives and premixed feed additives, forming a diversified product matrix covering both pharmaceuticals and nutritional products.

Innovation Driven: Integration of Industry, Academia, and Research, Productive Results

    Enho has always placed technological innovation at the core, establishing teaching and research practice bases with multiple domestic and international agricultural universities and research institutions, promoting deep integration of industry, academia, and research.

The company launched various brand series such as "Caomule," "Oenli," "Qianchong," "Langxin," and "Xuli," covering poultry, livestock, pets, fur animals, and aquaculture. In 2023, it passed the new version veterinary GMP certification, currently holding over 180 approved product licenses; in 2025, it passed the re-assessment for high-tech enterprise status; and in 2026, it passed the ISO 9001 quality management system certification re-assessment.

Looking Ahead: The Shanxi Business Way, Win-Win Development

    Participating in the 12th China Veterinary Medicine Expo, Enho leveraged this high-end industry platform not only to strengthen in-depth exchanges with industry peers but also to comprehensively demonstrate the company’s core advantages in animal health product research and technological innovation through a complete prevention, treatment, and inspection integrated service system.

Enho, in collaboration with Langxin Biotechnology and Zhuoxin Research Institute, has built a complete animal health industry ecosystem. Relying on the integrated strengths of research, production, and service, it continuously addresses disease and nutritional challenges in the farming industry. The company always focuses on long-term strategic partnerships, rejecting short-term profit-driven thinking, adhering to the principle of 'technology first, quality foremost.'